ACADEMIC AND RESEARCH PEER-REVIEWED MEDICAL JOURNALISSN 1727-2378
Ru
En

Diagnosis and Treatment of Abnormal Vaginal Discharge

DOI:10.31550/1727-2378-2018-150-6-26-29
Bibliography link: Dikke G. B. Diagnosis and Treatment of Abnormal Vaginal Discharge. Doctor.Ru. 2018; 6(150): 26–29.
Diagnosis and Treatment of Abnormal Vaginal Discharge
10 September 16:09

Objective of the Review: To assess the role of mixed flora in the development and recurrence of lower-genital-tract inflammation in women and to identify optimal treatment approaches for such patients.

Key Points: The article includes treatment recommendations, together with evaluations of the level of evidence for them and of their strength, for polymicrobial and/or relapsing disorders accompanied by abnormal vaginal discharge. The evaluations are based on an analysis of Cochrane Collaboration materials, the guidelines of leading professional associations, and clinical trials published in open-access and official sources.

Conclusion: Recent years’ changes in the epidemiology of vaginal infections (with high rates of coinfections) and the development of resistance to antimicrobial drugs necessitate new approaches and guidelines for the treatment and prevention of these infections.

G. B. Dikke — Peoples’ Friendship University of Russia, Moscow. E-mail: galadikke@yandex.ru

Diagnosis and Treatment of Abnormal Vaginal Discharge
10 September 16:09
LITERATURE
  1. Клинические рекомендации по ведению больных инфекциями, передаваемыми половым путем, и урогенитальными инфекциями. РОДВиК. М.: Деловой экспресс; 2012. 112 с. [Klinicheskiye rekomendatsii po vedeniyu bol'nykh infektsiyami, peredavayemymi polovym putem, i urogenital'nymi infektsiyami / RODViK. M .: Delovoy ekspress; 2012. 112 s. (in Russian)]
  2. Johnson H. L., Ghanem K. G., Zenilman J. M., Erbelding E. J. Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics. Sex Transm. Dis. 2011; 38(3): 167–71.
  3. Fan A., Yue Y., Geng N., Zhang H., Wang Y., Xue F. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch. Gynecol. Obstet. 2013; 287(2): 329–35.
  4. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. Заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и болезнями кожи (статистические материалы). М.; 2016. 207 c. [Resursy i deyatel'nost' meditsinskikh organizatsiy dermatovenerologicheskogo profilya. Zabolevayemost' infektsiyami, peredavayemymi polovym putem, zaraznymi kozhnymi boleznyami i boleznyami kozhi (statisticheskiye materialy). M.; 2016. 207 s. (in Russian)]
  5. Report on global sexually transmitted infection surveillance 2015. WHO, 2016. 54 p.
  6. WHO guidelines for the treatment of Chlamydia trachomatis. 2016. http://apps.who.int/iris/bitstream/10665/246165/1/9789241549714-eng.pdf (дата обращения — 15.10.2017).
  7. Дикке Г. Б. Полимикробные ассоциации в этиологии воспалительных заболеваний половых органов у женщин. Акушерство и гинекология. 2017; 6: 151–8. [Dikke G. B. Polimikrobnyye assotsiatsii v etiologii vospalitel'nykh zabolevaniy polovykh organov u zhenshchin. Akusherstvo i ginekologiya. 2017; 6: 151–8. (in Russian)]
  8. Sexually Transmitted Diseases Treatment Guidelines. CDC; 2015. https://www.cdc.gov (дата обращения — 15.10.2017).
  9. Федеральные клинические рекомендации по ведению больных урогенитальным трихомониазом. РОДВиК. М.; 2015. 13 c. [Federal'nyye klinicheskiye rekomendatsii po vedeniyu bol'nykh urogenital'nym trikhomoniazom. RODViK. M.; 2015. 13 s. (in Russian)]
  10. Федеральные клинические рекомендации по ведению больных бактериальным вагинозом. Акушерство и гинекология. 2016; 4(приложение): 43–9. [Federal'nyye klinicheskiye rekomendatsii po vedeniyu bol'nykh bakterial'nym vaginozom. Akusherstvo i ginekologiya. 2016; 4(prilozheniye): 43–9. (in Russian)].
  11. Федеральные клинические рекомендации по ведению больных урогенитальным кандидозом. Акушерство и гинекология. 2016; 4(приложение): 50–6. [Federal'nyye klinicheskiye rekomendatsii po vedeniyu bol'nykh urogenital'nym kandidozom. Akusherstvo i ginekologiya. 2016; 4(prilozheniye): 50–6. (in Russian)]
  12. Swidsinski A., Verstraelen H., Loening-Baucke V., Swidsinski S., Mendling W., Halwani Z. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS One. 2013; 8(1): e53997.
  13. Truter I., Graz M. Bacterial vaginosis: Literature review of treatment options with specific emphasis on non-antibiotic treatment. Review. Afr. J. Pharm. Pharmacol. 2013; 7(48): 3060–7.
  14. Geißdörfer W., Böhmer Ch., Pelz K., Schoerner Ch., Frobenius W., Bogdan Ch. Tuboovarian abscess caused by Atopobium vaginae following transvaginal oocyte recovery. J. Clin. Microbiol. 2003; 41(6): 2788–90.
  15. Gottschick C., Szafranski S. P., Kunze B., Sztajer H., Masur C., Abels C. et al. Screening of Compounds against Gardnerella vaginalis Biofilms. PLoS One. 2016; 11(4): e0154086.
  16. Радзинский В. Е., Хамошина М. Б., Шеленина Л. А., Климова О. И., Лебедева М. Г., Замотина И. В. Терапия вагинальных инфекций: грани проблемы (международные реалии и российский опыт). Доктор.Ру. 2013; 7(85): 13–17. [Radzinskii V. E., Khamoshina M. B., Shelenina L. A., Klimova O. I., Lebedeva M. G., Zamotina I. V. Terapiya vaginal'nykh infektsii: grani problemy (mezhdunarodnye realii i rossiiskii opyt). Doctor.Ru. 2013; 7(85): 13–17. (in Russian)]
  17. Подзолкова Н. М., Никитина Т. И. Новые возможности терапии рецидивирующих вульвовагинальных инфекций: анализ и обсуждение результатов многоцентрового исследования БИОС-2. Акушерство и гинекология. 2014; 4: 68–74. [Podzolkova N. M., Nikitina T. I. Novyye vozmozhnosti terapii retsidiviruyushchikh vul'vovaginal'nykh infektsiy: analiz i obsuzhdeniye rezul'tatov mnogotsentrovogo issledovaniya BIOS-2. Akusherstvo i ginekologiya. 2014; 4: 68–74. (in Russian)]
  18. Verstraelen H., Verhelst R., Roelens K., Temmerman M. Antiseptics and disinfectants for the treatment of bacterial vaginosis: a systematic review. BMC Infect. Dis. 2012; 12: 148.
  19. Kumar J. K., Kumar H., Reddy C., Gunashakaran V., Ramesh Y., Babu K. P. et al. Application of broad spectrum antiseptic povidone iodine as powerful action: a review. J. Pharm. Science Technol. 2009; 1(2): 48–58.
  20. Тихомиров А. Л., Казенашев В. В., Юдина Т. А. Эффективный антисептик в современной гинекологии. Рус. мед. журн. 2016; 24(15): 993–6. [Tikhomirov A. L., Kazenashev V. V., Yudina T. A. Effektivnyi antiseptik v sovremennoi ginekologii. Rus. med. zhurn. 2016; 24(15): 993–6. (in Russian)].
  21. Богомазова И. М., Белоусова В. С., Максимов М. Л. Эффективность использования препарата Бетадин при бактериальном вагинозе. Рус. мед. журн. 2014; 22(19): 1390. [Bogomazova I. M., Belousova V. S., Maksimov M. L. Effektivnost' ispol'zovaniya preparata Beta-din pri bakterial'nom vaginoze. Rus. med. zhurn. 2014; 22(19): 1390. (in Russian)]
  22. Petersen E. E., Weissenbacher E. R., Hengst P., Spitzbart H., Weise W., Wolff F. et al. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study. Arzneimit-telforschung. 2002; 52(9): 706–15.
  23. Sherrard J., Donders G., White D., Jensen J. S. European (IUSTI/WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2011; 22(8): 421–9.
  24. Workowski K., Berman S. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR Recomm. Rep. 2010; 59(RR–12): 1–110.
  25. Рахматулина М. Р., Цой Е. Г. Современные показатели резистентности грибов рода Candida к антимикотическим препаратам. Фарматека. 2017; S1: 22–5. [Rakhmatulina M. R., Tsoy Ye. G. Sovremennyye pokazateli rezistentnosti gribov roda Candida k antimikoticheskim preparatam. Farmateka. 2017; S1: 22–5. (in Russian)]
  26. Dellenbach P., Thomas J. L., Guerin V., Ochsenbein E., Contet-Audonneau N. Topical treatment of vaginal candidosis with sertaconazole and econazole sustained-release suppositories. Int. J. Gynaecol. Obstet. 2000; 71(suppl. 1): S47–52.
  27. Borelli C., Korting H. C., Bödeker R. H., Neumeister C. Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis. Cutis. 2010; 85(2): 107–11.
  28. Carrillo-Muñoz A. J., Fernández-Torres B., Cárdenes D. C., Guarro J. In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility. Chemotherapy. 2003; 49(5): 248–51.
  29. Palacin C., Guerrero M., M. Raga M., Romero A., Guglietta A. Pharmaceutical compositions of sertaconazole for vaginal use EP 1572201 A1 (патент WO2004054576A1).
  30. Carrillo-Munoz A. J., Torres-Rodriguez J. M. Invitro antifungal activity of sertaconazole, econazole, and bifonazole against Candida spp. J. Antimicrob. Chemother. 1995; 36(4): 713–6.
  31. Palacín C., Tarragó C., Agut J., Guglietta A. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp. Clin. Pharmacol. 2001; 23(2): 61–4.
  32. Wang P. H., Chao H. T., Chen C. L., Yuan C. C. Single-dose sertaconazole vaginal tablet treatment of vulvovaginal candidiasis. J. Chin. Med. Assoc. 2006; 69(6): 259–63.
  33. Donders G. G., Vereecken A., Bosmans E., Dekeersmaecker A., Salembier G., Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002; 109(1): 34–43.
  34. Han C., Wu W., Fan A., Wang Y., Zhang H, Chu Z. et al. Diagnostic and therapeutic advancements for aerobic vaginitis. Arch. Gynecol. Obstet. 2015; 291(2): 251–7.
  35. Gajdács M., Spengler G., Urbán E. Identification and antimicrobial susceptibility testing of anaerobic bacteria: rubik’s cube of clinical microbiology. Antibiotics. 2017; 6(4): PII: E25. DOI: 10.3390/antibiotics6040025
  36. Prayle A., Watson A., Fortnum H., Smyth A. Side effects of amino-glycosides on the kidney, ear and balance in cystic fibrosis. Thorax. 2010; 65(7): 654–8. DOI: 10.1136/thx.2009.131532
  37. American Society of Health-System Pharmacists. Drug Information 2016. Source: HSDB. Record Name: Kanamycin A. Bethesda, MD. 2016: 28. https://pubchem.ncbi.nlm.nih.gov/ (дата обращения — 14.04.2018).
  38. Kristich C. J., Rice L. B., Arias C. A. Enterococcal infection — treatment and antibiotic resistance. In: Gilmore M. S., Clewell D. B., Ike Y., Shankar N., eds. Enterococci: from commensals to leading causes of drug resistant infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014. https://www.ncbi.nlm.nih.gov/books/NBK190420/ (дата обращения — 14.04.2018).
  39. Tian C. F., Su B. Y., Li Y. J., Tong Y. H., Zhao X. H., Liang J. Y. at al. Management of antibiotic-associated pseudomembranous colitis in Non-hospitalized and hospitalized patients. Pak. J. Pharm. Sci. 2016; 29(5 suppl.): S1805–10.
  40. Gerding D. N. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin. Infect. Dis. 2004; 38(5): 646–8.
  41. Melkumyan A. R., Priputnevich T. V., Ankirskaya A. S., Murav'eva V. V., Lubasovskaya L. A. Effects of antibiotic treatment on the lactobacillus composition of vaginal microbiota. Bull. Exp. Biol. Med. 2015; 158(6): 766–8.
  42. Georgieva R., Yocheva L., Tserovska L., Zhelezova G., Stefanova N., Atanasova A. et al. Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnol. Biotechnol. Equip. 2015; 29(1): 84–91. DOI: 10.1080/13102818.2014.987450
  43. Donders G. G., Ruban K., Bellen G. Selecting antimicrobial treatment of aerobic vaginitis. Curr. Infect. Dis. Rep. 2015; 17(5): 477.
Similar article
19 May 15:04, Allergology
V.M. Ganuzin, N.L. Chernaya, G.S. Maskova
Features of Specialised Medical Consultation of Adolescents with Bronchial Asthma: Clinical Observation
Doctor.Ru Pediatrics. Vol. 19, No. 3 (2020)
19 May 14:30, Allergology
S.E. Mitskevich, I.A. Fedorov, A.I. Chuprynina, O.G. Rybakova
Use of Omalizumab in Management of Severe Uncontrolled Bronchial Asthma in Children
Doctor.Ru Pediatrics. Vol. 19, No. 3 (2020)

Partners